Indoco Remedies' Goa facility completes USFDA inspection

Indoco Remedies announced that the US Food and Drug Administration (USFDA) inspected Indoco's Sterile facility (Plant II) and Solid Dosages facility (Plant III) situated at L-32/33/34 Verna Industrial Estate, Goa from 14 November till 21 November, 2018. The inspection concluded with Indoco receiving 2 minor observations, none of which are repeat in nature. This facility had received a Warning Letter from the USFDA in March 2017.

Powered by Capital Market - Live News